NOVARTIS AG NAMENS-AKTIEN SF 0,5
NOVARTIS AG NAMENS-AKTIEN SF 0,5/ CH0012005267 /
904278
2024-09-06 10:58:48 PM
|
Chg.
-0.120
|
Volume |
Bid10:58:48 PM |
Ask10:58:48 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
104.540EUR
|
-0.11%
|
- Turnover: - |
104.540Bid Size: - |
105.960Ask Size: - |
240.16 bill.EUR |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
7.15 USD |
124.14% |
EPS Diluted: |
- USD |
123.97% |
Revenues per Share: |
20.49 USD |
-14.09% |
Book Value per Share: |
20.49 USD |
-26.91% |
Cash Flow per Share: |
6.35 USD |
227.31% |
Dividend per Share: |
3.90 USD |
4.00% |
Total |
in mill. |
|
Revenues: |
46,660.00 USD |
-7.69% |
Net Income: |
14,850.00 USD |
113.52% |
Operating Cash Flow: |
14,458.00 USD |
- |
Cash and Cash Equivalents: |
13,393.00 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
16.35 |
14.06 |
P/S Ratio: |
5.71 |
4.91 |
P/BV ratio: |
5.71 |
4.91 |
P/CF Ratio: |
18.41 |
15.84 |
PEG: |
0.13 |
0.11 |
Earnings Yield: |
6.12% |
7.11% |
Dividend Yield: |
3.34% |
3.88% |
Market Capitalization |
|
Market Capitalization: |
240.16 bill. EUR |
207.39 bill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
3.16 mill. EUR |
2.73 mill. EUR |
Shares Outstanding: |
2.03 bill. |
|
Profitability
Gross Profit Margin: |
73.27% |
EBIT Margin: |
20.94% |
Net Profit Margin: |
31.83% |
Return on Equity: |
31.82% |
Return on Assets: |
14.86% |
Financial Strength
Liquidity I / Cash Ratio: |
50.75% |
Liquidity II / Quick Ratio: |
77.68% |
Liquidity III / Current Ratio: |
115.50% |
Debt / Equity Ratio: |
114.17% |
Dynam. Debt / Equity Ratio: |
368.50% |
Efficiency
Employees: |
76,057 |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
613,487.25 USD |
Net Income / Employee: |
195,248.30 USD |
Total Assets / Employee: |
1,314,080.23 USD |
* Fiscal Year End: |
2023-12-31 |
Accounting Standard: |
IFRS |